run about to happen, page-5

Andy - not sure what you meant by marketing and sale - EMS is highly unlikely to manufacture and sell the Malaria treatment (which is why the Berlin Pharma thing is so important as they have the manufacturing rights) - there is most likely a need for further trials but they will be funded by prospective buyers in exchange for preferential treatment in the sale process

Though it would seem quiet to us I am told that things are moving behind the scenes and management is not being idle- but as is the way of these Pharmaceuticals news is not often

I do agree with you that the next announcement needs to be on time - given the small number of people deployed in the trial it seems that the independent audit requires a fair degree of time

Keep the faith

Clyde

Ramblings